Quantbot Technologies LP Invests $1.52 Million in Innospec Inc. $IOSP

Quantbot Technologies LP bought a new position in Innospec Inc. (NASDAQ:IOSPFree Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 15,996 shares of the specialty chemicals company’s stock, valued at approximately $1,516,000.

Other institutional investors have also recently made changes to their positions in the company. Envestnet Asset Management Inc. increased its position in Innospec by 14.9% during the 4th quarter. Envestnet Asset Management Inc. now owns 27,554 shares of the specialty chemicals company’s stock valued at $3,033,000 after buying an additional 3,578 shares in the last quarter. Barclays PLC increased its position in Innospec by 2.5% during the 4th quarter. Barclays PLC now owns 45,660 shares of the specialty chemicals company’s stock valued at $5,026,000 after buying an additional 1,101 shares in the last quarter. Guggenheim Capital LLC boosted its stake in Innospec by 11.5% during the 4th quarter. Guggenheim Capital LLC now owns 2,729 shares of the specialty chemicals company’s stock valued at $300,000 after purchasing an additional 281 shares during the last quarter. NewEdge Advisors LLC boosted its stake in Innospec by 195.2% during the 4th quarter. NewEdge Advisors LLC now owns 3,324 shares of the specialty chemicals company’s stock valued at $366,000 after purchasing an additional 2,198 shares during the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in Innospec during the 4th quarter valued at $936,000. Institutional investors own 96.64% of the company’s stock.

Analysts Set New Price Targets

Separately, Wall Street Zen downgraded Innospec from a “buy” rating to a “hold” rating in a research note on Tuesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Strong Buy”.

Check Out Our Latest Stock Report on Innospec

Innospec Stock Performance

Shares of Innospec stock opened at $87.12 on Friday. Innospec Inc. has a one year low of $74.10 and a one year high of $128.35. The stock’s fifty day moving average is $84.07 and its 200 day moving average is $90.56. The stock has a market cap of $2.16 billion, a P/E ratio of 111.69 and a beta of 1.07.

Innospec (NASDAQ:IOSPGet Free Report) last announced its earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.09. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The company had revenue of $439.70 million for the quarter, compared to analysts’ expectations of $440.70 million. During the same period last year, the firm earned $1.39 EPS. Innospec’s revenue for the quarter was up 1.1% compared to the same quarter last year. Analysts predict that Innospec Inc. will post 6.18 EPS for the current year.

Innospec Company Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Further Reading

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.